Viewing data from:

JAIMIESS

ANDA

ETHINYL ESTRADIOL; LEVONORGESTREL | A203770 | XIROMED PHARMA ESPANA SL

1 strength0 unique patents0 unique exclusivities

Reference Listed Drug: QUARTETTE(TE code: AB)

Medicare Part D Spending

CMS annual spending data for Jaimiess (2023)

Total Spending

$67K

Total Claims

972

Beneficiaries

425

Avg Cost/Unit

$0.76

Spending Trend

$29K(2020)→$62K(2021)→$84K(2022)→$67K(2023)

YoY Change:-14.1%

5yr CAGR:-15.0%

Source: CMS Medicare Part D Spending by Drug (2023). Shows gross drug cost under Part D.

Products (1)

#001 — 0.03MG,0.01MG;0.15MG,N/A

0 patents0 exclusivities▴

TABLET;ORAL | Approved: Dec 27, 2017

No patent or exclusivity listings for this strength.